PSME3 and melanoma: Aberrant overexpression of PSME3 has been revealed in a plethora of cancers, including pancreatic cancer, thyroid carcinoma, breast cancer, melanoma, oral cancer, non-small-cell lung cancer, and multiple myeloma [56].